These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1561683)

  • 1. Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.
    Rocca WA; Dorsey FC; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Bruno R; Carolei A; Sancesario G
    Stroke; 1992 Apr; 23(4):519-26. PubMed ID: 1561683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.
    Lenzi GL; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Carolei A; Dorsey FC; Rocca WA; Bruno R
    Stroke; 1994 Aug; 25(8):1552-8. PubMed ID: 8042206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside GM1 in acute ischemic stroke. The SASS Trial.
    Stroke; 1994 Jun; 25(6):1141-8. PubMed ID: 8202971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
    Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J
    Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosialoganglioside therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    Stroke; 1985; 16(5):899-900. PubMed ID: 3901426
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is ganglioside GM1 effective in the treatment of stroke?
    Braune S
    Drugs Aging; 1991 Jan; 1(1):57-66. PubMed ID: 1794005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
    del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
    Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.
    Dyker AG; Lees KR
    Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
    Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trials of monosialoganglioside (Sygen) treatment in ischemic stroke].
    Wender M; Mularek J; Godlewski A; Losy J; Michałowska-Wender G; Sniatała-Kamasa M; Wójcicka M
    Neurol Neurochir Pol; 1993; 27(1):31-8. PubMed ID: 8502357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
    Clark WM; Warach SJ; Pettigrew LC; Gammans RE; Sabounjian LA
    Neurology; 1997 Sep; 49(3):671-8. PubMed ID: 9305321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside.
    Grieco G; d'Hollosy M; Culliford AT; Jonas S
    Stroke; 1996 May; 27(5):858-74. PubMed ID: 8623106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.